October 23, 2026 08:55 am (IST)
Follow us:
Pfizer stops sale of Corex cough syrup in India after ban
Mumbai, Mar 14 (IBNS) Pharmaceutical major Pfizer has stopped manufacture and sale of popular cough syrup Corex with immediate effect after a ban by the Government.
“This is to inform you that the Government of India has prohibited the manufacture for sale, sale and distribution of fixed dose combination of Chlopheniramine Maleate + Codeine Syrup with immediate effect,” Pfizer said in a BSE filing on Monday.
“In view of this, the company has discontinued the manufacture and sale of its drug Corex with immediate effect," it said.
Pfizer said it believed Corex had a "well-established efficacy and safety profile in India for more than 30 years," adding that the company was "exploring all possible options at its disposal."
Pfizer said the prohibition on Corex is likely to have an adverse impact on the revenue and profitability of the company.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
Latest Headlines
Want happier kids? Scientists find a link between early parenting and teen brain health
Wed, Oct 14 2026
Peanuts may do more than you think! Study uncovers potential metabolic health benefits
Sun, Oct 11 2026
WHO’s big warning on child obesity: First global guidelines released
Wed, Oct 07 2026